Jamjoom Pharmaceuticals Factory Co. (4015)

• Stock
• Company Profile
• News
• Announcements
• Fair Values
• Corporate Actions
• Earning Announcements
• News Reports
• Major Shareholders
• Volume Statistics
• Financial Ratios
• IPOs
• Financial Statements
• Support and resistance
• More

{{ 'components.chart.period.' + period | translate }}

{{ 'components.chart.type.' + type | translate }}

This mark means that there are news on this date.

Stock

Par Value 10.0 Saudi Riyal

Market Cap 9,779,000,000.00 Saudi Riyal

Book Value (BVPS) 23.61 Saudi Riyal Based on: Third Quarter 2025

P/B Ratio 6.56 Last update: 2026-01-03

EPS 6.10 Saudi Riyal Based on: Third Quarter 2025

P/E Ratio 20.89 Last update: 2026-01-03

Trading Currency Saudi Riyal

Company Statistics

News

Jamjoom Pharma, PIF-backed Lifera launch JV to strengthen Saudi biopharma manufacturing ecosystem Companies Investments

Jamjoom Pharma’s net profits near SAR 396m in 9M-25 Financial Results

Jamjoom Pharma launches new brand identity to accelerate regional growth Global Economy

Jamjoom Pharma partners with Bio-Thera to secure Cosentyx biosimilar in MENA Global Economy

Jamjoom Pharma appoints new Chairman, Vice Chairman Board of Directors

Jamjoom Pharma logs SAR 157m net profits in Q1-25 Financial Results

Market Announcements